Low-dose dobutamine adds incremental value to delayed enhancement cardiac magnetic resonance for the prediction of adverse remodelling following acute myocardial infarction

Alistair Scott, Scott Ian Kay Semple, Thomas William Redpath, Gary Robert Small, Graham Hillis

Research output: Contribution to journalSpecial issuepeer-review

51 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Low-dose dobutamine adds incremental value to delayed enhancement cardiac magnetic resonance for the prediction of adverse remodelling following acute myocardial infarction'. Together they form a unique fingerprint.

Medicine & Life Sciences